EP2899191
Oxasólsetin indasól sem PI3-kínasahindrar
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
28.4.2010EP published:
9.8.2017EP application number:
14194866.1
EP translation filed:
9.10.2017Grant published:
15.11.2017EPO information:
European Patent Register
Max expiry date:
27.4.2030Expiry date:
27.4.2021
Title:
OXAZOLE SUBSTITUTED INDAZOLES AS PI3-KINASE INHIBITORS
Timeline
Today
28.4.2010EP application
9.8.2017EP Publication
9.10.2017Translation submitted
15.11.2017Registration published
27.4.2021Expires
Owner
Name:
Glaxo Group LimitedAddress:
980 Great West Road, TW8 9GS, Brentford, Middlesex, GB
Inventor
Name:
Hamblin, Julie NicoleAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
Jones, Paul SpencerAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
Keeling, Suzanne ElaineAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
Le, JoelleAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
Mitchell, Charlotte JaneAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
Parr, Nigel JamesAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
174033 PDate:
30.4.2009Country:
US
Classification
Categories:
C07D 413/14, A61K 31/497, A61K 31/535, A61P 35/00, A61P 37/00, A61P 11/00, A61P 31/12
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 13.3.2018
Expires: 27.4.2019
Payer: Örn Þór, slf.
Number: 10
Paid: 13.3.2019
Expires: 27.4.2020
Payer: Örn Þór, slf.
Number: 11
Paid: 13.3.2020
Expires: 27.4.2021
Payer: Örn Þór slf.